Ovid Therapeutics
OVID
$3.74
Share price
2.75%
Change (1 day)
68.47%
Change (1 year)
Categories
Operating Margin for Ovid Therapeutics (OVID)
Operating Margin as of September 2023 (TTM): -3,370.91%
According to Ovid Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -3,370.91%. At the end of 2021 the company had an Operating Margin of 59.61%.
Operating Margin history for Ovid Therapeutics from 2022 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 59.61% | -109.24% |
| 2020 | -645.40% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.